col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer-Verlag: Molecular Diversity
  original article Date Title Authors   All Authors
1 [GO] 2021―Sep―04 Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 Mpro Anbuselvam Mohan, Nicole Rendine, Mohammed Kassim Sudheer Mohammed, Anbuselvam Jeeva, Hai-Feng Ji, Venkateswara Rao Talluri
2 [GO] 2021―Jul―09 Hemagglutinin-esterase cannot be considered as a candidate for designing drug against COVID-19 Milad Zandi, Saber Soltani
3 [GO] 2021―Jul―02 In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2 Rahman Abdizadeh, Farzin Hadizadeh, Tooba Abdizadeh
4 [GO] 2021―Jun―24 New insights into the catalytic mechanism of the SARS-CoV-2 main protease: an ONIOM QM/MM approach Henrique S. Fernandes, Sérgio F. Sousa, Nuno M. F. S. A. Cerqueira
5 [GO] 2021―Jun―12 Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study R. P. Vivek-Ananth, Sankaran Krishnaswamy, Areejit Samal
6 [GO] 2021―Jun―09 Investigating the active compounds and mechanism of HuaShi XuanFei formula for prevention and treatment of COVID-19 based on network pharmacology and molecular docking analysis Juan Wang, Wen Ge, Xin Peng, Lixia Yuan, Shuaibing He, Xuyan Fu
7 [GO] 2021―May―18 Meticulous assessment of natural compounds from NPASS database for identifying analogue of GRL0617, the only known inhibitor for SARS-CoV2 papain-like protease (PLpro) using rigorous computational workflow Paritosh Parmar, Priyashi Rao, Abhilasha Sharma, Arpit Shukla, Rakesh M. Rawal, Meenu Saraf, et al. (+2)
8 [GO] 2021―May―07 Identification of phytocompounds from Houttuynia cordata Thunb. as potential inhibitors for SARS-CoV-2 replication proteins through GC-MS/LC-MS characterization, molecular docking and molecular dynamics simulation Sanjib Kumar Das, Saurov Mahanta, Bhaben Tanti, Hui Tag, Pallabi Kalita Hui
9 [GO] 2021―Apr―15 Identification of potential plant-based inhibitor against viral proteases of SARS-CoV-2 through molecular docking, MM-PBSA binding energy calculations and molecular dynamics simulation Bhaskarjyoti Gogoi, Purvita Chowdhury, Nabajyoti Goswami, Neelutpal Gogoi, Tufan Naiya, Pankaj Chetia, et al. (+5)
10 [GO] 2021―Apr―12 Structure-based identification of SARS-CoV-2 main protease inhibitors from anti-viral specific chemical libraries: an exhaustive computational screening approach Shovonlal Bhowmick, Achintya Saha, Sameh Mohamed Osman, Fatmah Ali Alasmary, Tahani Mazyad Almutairi, Md Ataul Islam
11 [GO] 2021―Apr―06 Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation Priyashi Rao, Rohit Patel, Arpit Shukla, Paritosh Parmar, Rakesh M. Rawal, Meenu Saraf, Dweipayan Goswami
12 [GO] 2021―Mar―30 Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors Anshul Shakya, Rupesh V. Chikhale, Hans Raj Bhat, Fatmah Ali Alasmary, Tahani Mazyad Almutairi, Surajit Kumar Ghosh, et al. (+4)
13 [GO] 2021―Mar―25 In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase Ismail Celik, Meryem Erol, Zekeriya Duzgun
14 [GO] 2021―Mar―06 Exploring naphthyl derivatives as SARS-CoV papain-like protease (PLpro) inhibitors and its implications in COVID-19 drug discovery Sk. Abdul Amin, Kalyan Ghosh, Samayaditya Singh, Insaf Ahmed Qureshi, Tarun Jha, Shovanlal Gayen
15 [GO] 2021―Feb―14 Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19 Himanshu Rai, Atanu Barik, Yash Pal Singh, Akhil Suresh, Lovejit Singh, Gourav Singh, et al. (+3)
16 [GO] 2021―Jan―25 Computational assessment of saikosaponins as adjuvant treatment for COVID-19: molecular docking, dynamics, and network pharmacology analysis Rupesh Chikhale, Saurabh K. Sinha, Manish Wanjari, Nilambari S. Gurav, Muniappan Ayyanar, Satyendra Prasad, et al. (+4)
17 [GO] 2021―Jan―05 First structure-activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery Sk. Abdul Amin, Suvankar Banerjee, Samayaditya Singh, Insaf Ahmed Qureshi, Shovanlal Gayen, Tarun Jha
18 [GO] 2021―Jan―05 COVID-19: inflammatory responses, structure-based drug design and potential therapeutics Neetu Tripathi, Neeraj Tripathi, Manoj Kumar Goshisht
19 [GO] 2021―Jan―04 Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19) Shobha Upreti, Jyoti Sankar Prusty, Satish Chandra Pandey, Awanish Kumar, Mukesh Samant
20 [GO] 2021―Jan―04 Curse of La Corona: unravelling the scientific and psychological conundrums of the 21st century pandemic Arpit Shukla, Paritosh Parmar, Gitanjali Kapoor, Dweipayan Goswami, Chaitanya Kumar Jha, Baldev Patel, Meenu Saraf
21 [GO] 2021―Jan―03 CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy Amgad M. Rabie
22 [GO] 2021―Jan―03 The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico Abdo A. Elfiky, Eman B. Azzam, Medhat W. Shafaa
23 [GO] 2021―Jan―02 Designing of peptide aptamer targeting the receptor-binding domain of spike protein of SARS-CoV-2: an in silico study Arpita Devi, Nyshadham S. N. Chaitanya
24 [GO] 2020―Nov―25 Computational guided identification of a citrus flavonoid as potential inhibitor of SARS-CoV-2 main protease Neelutpal Gogoi, Purvita Chowdhury, Ashis Kumar Goswami, Aparoop Das, Dipak Chetia, Bhaskarjyoti Gogoi
25 [GO] 2020―Nov―17 Molecular docking studies, molecular dynamics and ADME/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2 Olusola Olalekan Elekofehinti, Opeyemi Iwaloye, Sunday Solomon Josiah, Akeem Olalekan Lawal, Moses Orimoloye Akinjiyan, Esther Opeyemi Ariyo
26 [GO] 2020―Oct―20 Using Chou’s 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors Hemlata Pundir, Tanuja Joshi, Tushar Joshi, Priyanka Sharma, Shalini Mathpal, Subhash Chandra, Sushma Tamta
27 [GO] 2020―Sep―30 A multimodal deep learning-based drug repurposing approach for treatment of COVID-19 Seyed Aghil Hooshmand, Mohadeseh Zarei Ghobadi, Seyyed Emad Hooshmand, Sadegh Azimzadeh Jamalkandi, Seyed Mehdi Alavi, Ali Masoudi-Nejad
28 [GO] 2020―Sep―29 Identification of potential inhibitors of coronavirus hemagglutinin-esterase using molecular docking, molecular dynamics simulation and binding free energy calculation Chirag N. Patel, Sivakumar Prasanth Kumar, Himanshu A. Pandya, Rakesh M. Rawal
29 [GO] 2020―Sep―02 Therapeutics for COVID-19: from computation to practices-where we are, where we are heading to Probir Kumar Ojha, Supratik Kar, Jillella Gopala Krishna, Kunal Roy, Jerzy Leszczynski
30 [GO] 2020―Jul―31 Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach Ashish M. Kanhed, Dushyant V. Patel, Divya M. Teli, Nirav R. Patel, Mahesh T. Chhabria, Mange Ram Yadav
31 [GO] 2020―Jun―29 Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19 Tanuja Joshi, Priyanka Sharma, Tushar Joshi, Hemlata Pundir, Shalini Mathpal, Subhash Chandra


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.012 sec